Dr. Kousrali Sayyad

About

Hi,
I am taking this opportunity to introduce myself as Dr. KOUSR ALI SAYYAD, PhD, Analytical Chemistry, studied at KL University in Vijayawada. I have a total of 10 years experience in the pharmaceutical industry, Spinco biotech & Agilent Technologies. I am currently working as a field application engineer at Agilent technologies India Pvt. Ltd., Hyderabad.
I am well versed in analytical instruments like HPLC, GC, ICPMS, LCMS, GCMS, etc. Core competencies lie in analytical method development, validation and transfer activities, calibration of analytical instruments, and handling of extractable and leachable studies.
Possess inherent communication, team management, and strong organizational skills. Creative and innovative analytical approach with practical problem-solving ability, flair for continuous improvement and development, diligence, openness to ideas, and willingness to learn.

Employment

• Agilent Technologies (India) Field Application Engineer
  2024 - Present
• Spinco Tech LLP Filed Application Specialist (Team Leader)
  2022 - 2024
• Gland Pharma Assistant Manager
  2021 - 2022
• Suven Life Sciences (India) Senior Research Associate
  2020 - 2021
• Invitron Advanced Analytics Pvt Ltd Executive
  2016 - 2020

Education

• KL Deemed to be University PhD
  2019 - 2025
• Andhra University M.Sc
  2014 - 2016

Projects & Funding

Projects & funding information is unavailable.

Publications (22)

• A quality by design-based green LC–MS/MS method for the quantification of potential genotoxic isocyanate and amine impurities in angiotensin II receptor blockers.
  Microchemical Journal 2026 DOI: 10.1016/j.microc.2026.119321
  +Save
• Analytical Method Development and Validation of N‐Nitrosodibenzylamine in Lacosamide Drug Using LC–MS/MS Method: Quantification and Greenness Assessment
  SEPARATION SCIENCE PLUS 2026 DOI: 10.1002/sscp.70281
  +Save
• Quantification of 24 inorganic impurities in vismodegib and idelalisib anticancer drug substances using ICP-MS
  Journal of AOAC International 2026 DOI: 10.1093/jaoacint/qsag055
  +Save
• A method for simultaneous bioanalytical determination of semaglutide and liraglutide in human plasma using green lc-ms/ms technique with stable isotope-labelled internal standards and hybrid sample preparation
  Indian Patent 2026
  +Save
• Green Tandem Mass Spectrometry Method for Carcinogenic Nitrosamine Impurity Determination in Oral‐Gonadotropin Releasing Hormone Receptor Antagonist Drug
  SEPARATION SCIENCE PLUS 2026 DOI: 10.1002/sscp.70251
  +Save
• Evaluation and Measurement of Potential Genotoxic Impurities in Empagliflozin Active Pharmaceutical Ingredient Using Tandem Liquid Chromatography Mass Spectrometer, Accompanied by an Advanced Greenness Assessment
  SEPARATION SCIENCE PLUS 2026 DOI: 10.1002/sscp.70236
  +Save
• Estimation of Antimicrobial Agent (Sorbic Acid) in Semisolid Dosage Form (Gel) Using Liquid Chromatography and Evaluation of Its Stability in the Presence of Steroids, Polymers, and Low pH
  Biomedical Chromatography 2026 DOI: 10.1002/bmc.70412
  +Save
• A greener path to precision: Novel LC-MS/MS method for accurate digoxin quantification in human plasma: Green assessment with advanced metrics.
  Microchemical Journal 2026 DOI: 10.1016/j.microc.2025.116739
  +Save
• A sustainable LC–MS method for determination of genotoxic impurity 1-(2-chloroacetyl)pyrrolidine-2-carboxamide (CAPCA): Assessment by advanced green analytical metrics
  Microchemical Journal 2026 DOI: 10.1016/j.microc.2026.119271
  +Save
• Carcinogenic nitrosamine impurity (1-nitrosopiperidine-3-amine) determination in linagliptin drug substance by liquid chromatography tandem mass spectrometry: Greenness assessment by advance metrics
  Microchemical Journal 2025 DOI: 10.1016/j.microc.2025.114717
  +Save